NPHS1 and lipoid nephrosis: A recent report showed that B-cell depleting therapy was effective at controlling disease activity in one case of minimal change disease positive for anti-nephrin antibodies [13]. However, Shirai et al. [4] reported that nine of 11 kidney transplant recipients with FSGS recurrence achieved remission despite treatment with and without plasmapheresis and rituximab.